Literature DB >> 8601102

The European Medicines Evaluation Agency.

A Herxheimer.   

Abstract

Mesh：

Year:  1996        PMID： 8601102      PMCID： PMC2350087          DOI： 10.1136/bmj.312.7028.394

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  3 in total

1.  Status of new medicines approved by the European Medicines Evaluation Agency regarding paediatric use.

Authors:  P Impicciatore; I Choonara
Journal:  Br J Clin Pharmacol       Date:  1999-07       Impact factor: 4.335

2.  The European Medicines Evaluation Agency: open to criticism. Transparency must be coupled with greater rigour.

Authors:  K Abbasi; A Herxheimer
Journal:  BMJ       Date:  1998-10-03

3.  Risk minimization activities of centrally authorized products in the EU: a descriptive study.

Authors:  Inge M Zomerdijk; Fakhredin A Sayed-Tabatabaei; Gianluca Trifirò; Stella C F Blackburn; Miriam C J M Sturkenboom; Sabine M J M Straus
Journal:  Drug Saf       Date:  2012-04-01       Impact factor: 5.606
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.